​

Corcept Therapeutics Ownership | Who Owns Corcept Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Corcept Therapeutics Ownership Summary

Corcept Therapeutics is owned by 75.78% institutional investors, 11.55% insiders, and 12.67% retail investors. Blackrock is the largest institutional shareholder, holding 16.09% of CORT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.35% of its assets in Corcept Therapeutics shares.

CORT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCorcept Therapeutics75.78%11.55%12.67%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock16.54M16.09%$537.36M
Blackrock funding, inc. /de12.53M12.04%$919.76M
Vanguard group10.12M9.79%$509.73M
Ingalls & snyder8.10M7.84%$408.15M
Renaissance6.20M6.00%$312.35M
Parallel advisors3.83M3.70%$192.98M
State street3.55M3.43%$178.80M
Dimensional fund advisors lp2.08M2.01%$104.74M
Geode capital management2.07M2.00%$104.24M
Fmr1.34M1.29%$67.38M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ingalls & snyder8.10M16.01%$408.15M
Tanaka capital management111.55K12.85%$5.62M
Birchview capital, lp67.20K4.90%$4.93M
Parallel advisors3.83M4.34%$192.98M
Livforsakringsbolaget skandia, omsesidigt113.16K3.58%$82.18M
S&t bank/pa156.69K2.52%$7.90M
Synergy asset management258.49K2.17%$18.97M
Fas wealth partners302.43K1.64%$22.20M
Intrinsic edge capital management147.56K1.52%$10.83M
Lisanti capital growth46.36K0.94%$3.40M

Top Buyers

HolderShares% AssetsChange
Norges bank834.59K0.01%834.59K
Epoch investment partners765.40K0.29%765.40K
T. rowe price investment management566.27K0.03%566.27K
Braun stacey associates296.39K0.56%296.39K
Millennium management508.36K0.01%269.13K

Top Sellers

HolderShares% AssetsChange
Novo---2.41M
Blackrock funding, inc. /de12.53M0.02%-2.16M
Ikarian capital---994.50K
Arrowstreet capital, limited partnership788.81K0.04%-703.42K
Boston trust walden899.06K0.32%-614.91K

New Positions

HolderShares% AssetsChangeValue
Norges bank834.59K0.01%834.59K$42.06M
Epoch investment partners765.40K0.29%765.40K$56.18M
T. rowe price investment management566.27K0.03%566.27K$41.56M
Braun stacey associates296.39K0.56%296.39K$14.94M
Adage capital partners gp96.17K0.01%96.17K$7.06M

Sold Out

HolderChange
Claris advisors, llc / mo /-6.00
Mendota financial group-7.00
Global financial private client-13.00
Nelson, van denburg & campbell wealth management group-16.00
Stephens consulting-25.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025432-3.79%78,890,554-3.87%751.22%221-7.14%15410.79%
Mar 31, 202544914.83%82,236,144-2.40%781.19%23615.12%14015.70%
Dec 31, 202438312.98%84,233,711-3.36%811.15%20015.61%12014.29%
Sep 30, 202433511.67%87,110,973-2.41%841.12%17420.00%101-11.40%
Jun 30, 2024295-4.53%89,230,600-3.86%861.06%141-16.07%11328.41%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.64M5.35%800.00
Vanguard Total Stock Mkt Idx Inv2.83M2.69%-59.65K
Vanguard US Total Market Shares ETF2.83M2.68%213.93K
Vanguard Small Cap Index2.19M2.08%-13.82K
iShares Russell 2000 ETF2.03M1.91%-
Vanguard Small Cap Growth Index Inv1.23M1.17%-1.94K
Vanguard Institutional Extnd Mkt Idx Tr1.01M0.96%-440.96K
iShares S&P Small-Cap 600 Growth ETF824.88K0.78%-
Fidelity Small Cap Index819.47K0.78%2.47K
SPDR® Portfolio S&P 600™ Sm Cap ETF817.25K0.78%456.00

Recent Insider Transactions

DateNameRoleActivityValue
Aug 22, 2025Robb Gary Charles Chief Business OfficerSell$165.77K
Aug 11, 2025Swisher Daniel N JR-Sell$159.06K
Aug 08, 2025Guyer William Chief Development OfficerSell$2.51M
Aug 05, 2025Guyer William Chief Development OfficerSell$1.00K
Aug 01, 2025Maduck Sean See RemarksSell$1.88M

Insider Transactions Trends

DateBuySell
2025 Q3-21
2025 Q2-36
2025 Q1-22
2024 Q4-7
2024 Q3-8

CORT Ownership FAQ

Who Owns Corcept Therapeutics?

Corcept Therapeutics shareholders are primarily institutional investors at 75.78%, followed by 11.55% insiders and 12.67% retail investors. The average institutional ownership in Corcept Therapeutics's industry, Biotech Stocks , is 304.14%, which Corcept Therapeutics falls below.

Who owns the most shares of Corcept Therapeutics?

Corcept Therapeutics’s largest shareholders are Blackrock (16.54M shares, 16.09%), Blackrock funding, inc. /de (12.53M shares, 12.04%), and Vanguard group (10.12M shares, 9.79%). Together, they hold 37.91% of Corcept Therapeutics’s total shares outstanding.

Does Blackrock own Corcept Therapeutics?

Yes, BlackRock owns 16.09% of Corcept Therapeutics, totaling 16.54M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 537.36M$. In the last quarter, BlackRock decreased its holdings by -287K shares, a -1.71% change.

Who is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested?

Ingalls & snyder is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested, with 16.01% of its assets in 8.1M Corcept Therapeutics shares, valued at 408.15M$.

Who is the top mutual fund holder of Corcept Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Corcept Therapeutics shares, with 5.35% of its total shares outstanding invested in 5.64M Corcept Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools